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Surface-associated bacterial communities known as biofilms are an important source of nosocomial infections. Microorganisms such as Pseudomonas aeruginosa can colonize the abiotic surfaces of medical implants,
leading to chronic infections that are difficult to eradicate. Our study demonstrates that polysorbate 80 (PS80),
a surfactant commonly added to food and medicines, is able to inhibit biofilm formation by P. aeruginosa on
a variety of surfaces, including contact lenses. Many clinical isolates of P. aeruginosa, as well as gram-negative
and gram-positive clinical isolates, were also inhibited in their ability to form biofilms in the presence of PS80.
A P. aeruginosa mutant able to form biofilms in the presence of this surfactant was identified and characterized,
and it was revealed that this mutant overexpresses a lipase, LipA. Surfactants such as PS80 can be cleaved by
lipases, and we demonstrate that PS80 is cleaved by LipA at its ester bond. Finally, polyethoxylated(20) oleyl
alcohol, a chemical with a structure that is similar to that of PS80 but that lacks the ester bond of PS80, can
inhibit the biofilm formation of P. aeruginosa strains, including the mutant overexpressing LipA. Our results
demonstrate that surfactants such as PS80 can inhibit bacterial biofilm formation on medically relevant
materials at concentrations demonstrated to be safe in humans and suggest that the understanding of the
mechanisms of bacterial resistance to such surfactants will be important in developing clinically effective
derivatives.

tachment of microorganisms to abiotic surfaces with the goal
of reducing the rate of infections related to biofilm formation.
Several approaches relate to modifying the physical properties
of the surface to render it antiadhesive, while others create a
surface with antibacterial properties (for a recent review, see
reference 25). To work toward achieving this goal, several
studies have focused on coating abiotic surfaces with both
synthetic surfactants and biosurfactants. Surfactants are amphiphilic molecules, as they contain both hydrophilic and hydrophobic moieties that allow them to be easily immobilized
on a surface, and are commonly used to lower the surface
tension of a material. Surfactants have been shown to inhibit
the adhesion of gram-negative and gram-positive bacteria to
solid surfaces (14, 18, 29, 33, 37). When the impact of surfactants on microbial life is considered, cationic surfactants (such
as quaternary imidazolium compounds) are often the most
toxic to microorganisms and are used as antimicrobials. Anionic surfactants like sodium dodecyl sulfate are usually less
active and are mostly effective against gram-positive bacteria,
whereas nonionic surfactants are considered to have no antibacterial properties (38).
Polysorbate 80 (PS80) is a nonionic surfactant commonly
added to foods, cosmetics, and pharmaceutical preparations as
an emulsifier and dispersing agent and is considered to be well
tolerated when it is delivered to mucosal, intradermal, and
intravenous sites (21). It is derived from polyoxylated sorbitol
and oleic acid and is viscous but water soluble, which makes it
an additive of choice for vaccines, oil-based medical preparations, as well as topical ophthalmic medications.
There have been reports on the effects of PS80 on bacteria
for more than four decades. While it possesses little antimi-

Compounds that are tolerated by eukaryotic cells and that
are able to inhibit bacterial biofilm formation would have widespread clinical value. Bacterial biofilms are surface-attached
communities of microorganisms embedded in an extracellular
matrix made of a mix of exopolysaccharides, DNA, and proteins. The bacteria growing in a biofilm are able to survive
more successfully in hostile environments than non-surfaceattached (planktonic) bacteria. Bacteria grown in a biofilm
have increased resistance to antibiotics (17) and to the host
immune system compared to that of their planktonic counterparts (11, 15). In the past decade, an increasing number of
infections that involve bacterial biofilms have been identified
(6, 9). The NIH has estimated that up to 80% of clinical
infections are biofilm infections (8), with Staphylococcus spp.
and Pseudomonas aeruginosa cited as frequently identified
pathogens. Bacterial biofilms have been observed on medical
implants such as catheters, joint prostheses, cardiac valves, and
contact lenses (6, 9). Unlike most human tissues, these abiotic
surfaces lack properties to prevent bacterial attachment or
colonization and become a microbial reservoir that can lead to
chronic infections. These infections lead to higher costs for
patient care, since prostheses and implants must very often be
removed and replaced to eliminate the infection (7).
Various approaches are being developed to reduce the at-
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crobial activity alone, PS80 can increase bacterial cell permeability (4) and enhance the antimicrobial activity of a variety of
antibiotics against P. aeruginosa, including chlorhexidine diacetate, benzalkonium chloride, and polymyxin B sulfate (2, 3, 5,
27, 28). On the basis of these findings and studies indicating
that PS80 lyses spheroplasts (gram-negative bacteria in which
the outer membrane has been removed), Brown and colleagues proposed that PS80 is primarily active against the inner
membrane of P. aeruginosa (2). According to this view, its
capacity to enhance the activity of antimicrobial agents that
damage the outer membrane is thus a reflection of its ability to
gain access to the inner membrane in the presence of these
compounds.
In this report, we describe the PS80-mediated inhibition of
biofilm formation by P. aeruginosa and other gram-negative
and gram-positive bacterial species. We also present evidence
that P. aeruginosa PA14 can resist the action of PS80 by cleavage of this surfactant by a secreted lipase, showing one possible resistance pathway for this organism.
MATERIALS AND METHODS
Bacterial strains and media. All P. aeruginosa strains used in this study were
derived from P. aeruginosa PA14 (26), unless otherwise specified, and the mutants screened were obtained from the PA14 Transposon Insertion Library (16).
All clinical isolates came from the laboratory strain collection. Escherichia coli
JM109 recA1 supE44 endA1 hsdR17 gyrA96 relA1 thi ⌬(lac-proAB) F⬘ [traD36
proAB⫹ lacIq lacZ⌬M15] was used as the host strain for plasmid construction and
propagation, whereas E. coli S17-1pir recA thi hsdRM⫹ RP4::2-Tc::Mu::Km Tn7
pir was used for conjugations with P. aeruginosa. Saccharomyces cerevisiae strain
InvSc1 (Invitrogen, Carlsbad, CA) was used for in vivo homologous recombination for plasmid construction, as described previously (31). Selections of the S.
cerevisiae yeast strains were performed with a synthetic defined agar (0.67% yeast
nitrogen base [Research Products International, Mt. Prospect, IL], 0.076% complete supplement mixture without uracil [Sunrise Science Products, San Diego,
CA], 1.5% dextrose [Sigma, St. Louis, MO], 2% agar [Difco, Franklin Lakes,
NJ]) without uracil.
All bacterial strains were grown in LB medium (30) at 37°C, unless otherwise
noted, and their growth was monitored at an optical density of 600 nm (OD600).
All supernatants tested were obtained from overnight cultures centrifuged at
8,000 ⫻ g for 1 min and filtered through 0.2-m-pore-size filters (Millipore,
Billerica, MA). Ampicillin was used at 150 g/ml for E. coli. Carbenicillin was
used at 500 g/ml for P. aeruginosa. Gentamicin was used at 10 g/ml for E. coli
and 50 to 100 g/ml for P. aeruginosa.
PS80 (Spectrum Chemicals, Gardena, CA) was prepared as a 1% solution in
double-distilled water (water is referred to as vehicle in the rest of the text) and
was used at a concentration of 0.01%, unless otherwise noted. Oleic acid (Fluka/
Sigma, St. Louis, MO) was prepared as a 10% solution in 95% ethanol. Pseudomonas species lipase (type XIII; Sigma) was prepared as a 10-mg/ml solution in
Tris-EDTA buffer, and polyethoxylated(20) oleyl alcohol (Pragmatics Inc.,
Elkhart, IN) was used at a concentration of 0.01% from a 1% solution prepared
in double-distilled water. For arabinose-inducible plasmid plipA, 0.2% arabinose
was added to the cultures.
Biofilm assays and microscopy experiments. Biofilm assays in microtiter
dishes were performed as described previously (19, 23). All biofilms were incubated for 24 h at 37°C. The amount of biofilm present in each well was measured
by solubilization of crystal violet with 50% acetic acid and quantification at an
OD550. All biofilm data presented come from one representative experiment,
with four replicates per strain, of a minimum of three independent assays. Other
similar experiments showed the same trend and were internally controlled, but
because LB medium, which is a rich medium, was used, the data varied from one
experiment to the other. Supernatants from overnight cultures were heated at
65°C for 20 min, when necessary.
Attachment to polyvinyl chloride (PVC) and contact lenses made of etafilcon
A or vifilcon A (Surevue [Johnson & Johnson] and Focus [Ciba Vision], respectively) was visualized and measured by using a variation of the air-liquid interface
coverslip assay (19). Tabs of PVC and contact lenses were cut with a sterilized
pair of scissors. The PVC tabs were then sterilized by immersion in 70% ethanol.
Each tab was added to 1 well of a 12-well plate. The wells were filled with 250 l
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of M63 minimal medium (24) supplemented with MgSO4 (1 mM), glucose
(0.2%), and Casamino Acids (0.5%) containing a 1:100 dilution of the bacterial
strains tested (from overnight cultures). The plates were incubated at 37°C for
24 h. The tabs were then removed, rinsed four times in sterile phosphatebuffered saline to remove the planktonic cells, and then placed individually in the
wells of a 12-well plate containing enough phosphate-buffered saline to cover
each tab. Phase-contrast microscopic observations were performed with a DM
IRB inverted microscope (Leica Microsystems, Wetzlar, Germany) equipped
with a cooled charge-coupled-device digital camera and a 63X PL Flotar objective lens. Digital images were captured and analyzed with OpenLab software
(Improvision, Coventry, England).
CFU counts from biofilm cells. The direct enumeration of the bacteria present
in biofilms grown in the wells of a PVC plate was performed by a previously
published protocol (19). A minimum of four replicates was done per strain and
condition.
Lipase activity plate assay. Tributyrin plates were prepared by a protocol
modified from that of Smeltzer et al. (34). Briefly, a HEPES buffer (20 mM
HEPES, 500 mM NaCl, pH 7.4) was prepared and was warmed to 50°C. One
gram of agarose was added to 50 ml of HEPES buffer and melted in a microwave.
Simultaneously, 500 l of tributyrin (Sigma) was added to 50 ml of HEPES
buffer. This mix was sonicated at 35% for 3 min to create a white emulsion that
was then mixed with the agarose and poured into four petri plates. After solidification, 5 l of filtered supernatant of each of the strains of interest was spotted
on the plates. Five replicates were spotted per strain. The plates were incubated
at room temperature, and the diameter (in millimeters) of the zone of clearing,
which corresponded to the lipase/esterase activity of the sample, was measured
from a minimum of three plates after 3 days of incubation. Pseudomonas species
lipase (type XIII) was used as positive control.
Quantitative real-time PCR. Quantitative reverse transcriptase PCR (qRTPCR) was done by the use of previously published protocols (12, 13) with the
following modifications. The strains of interest were subcultured in LB medium
at 37°C until they reached an OD600 close to 0.4. The cells were normalized to
an OD600 of 0.4. After a brief centrifugation to pellet the cells, RNA was isolated
and cDNA was prepared as published previously (13). In the qRT-PCR experiment, the expression of each gene was measured in triplicate. All gene expression profiles were normalized to that for the rplU housekeeping gene. Expression
levels were quantified as the number of picograms of input cDNA by using a
standard curve method for absolute quantification, and these values were normalized to the level of rplU expression. The primers used in the qRT-PCR assays
were primers CT0140 (5⬘-CTCGCTGCCAGCCCTCTGATCC) and CT0141
(5⬘-GGTGGCGGAAGCGATCAGGTCG) for lipA and primers rplU1 (5⬘-CG
CAGTGATTGTTACCGGTG) and rplU2 (5⬘-CAACCGCAATGGGCGCTAT
TGC) for the rplU control.
Construction of lipA::pMQ87Ap. The single-crossover knockout vector
pMQ87 (31) was first modified as follows. The gentamicin resistance cassette was
replaced by the ampicillin resistance cassette by using a yeast-based cloning
system (31). The ampicillin resistance cassette was amplified from pMQ70 (31)
by PCR with primers p70for (5⬘-AGGAAGAGTATGAGTATTCAACCGAAT
TGACATAAGCCTGTATGTATCCGCTCATGAGAC) and p70rev (5⬘-ACTC
ACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGTCAGTGGAAC
GAAAACTCAC). The 1,000-bp fragment was cloned in pMQ87 (which was
linearized by digestion with BglII) by in vivo homologous recombination in yeast
cells (31). Plasmids were recovered from the yeast as described previously (31)
and transformed into E. coli S17-1pir, and plasmid candidates were screened on
a plate (growth on ampicillin and not gentamicin) as well as by PCR with primers
p70for and p70rev (see above). One candidate, pMQ87Ap, was selected for
further use.
The single-crossover knockout mutant of lipA in the mutant 3A8 background
was generated by using the newly obtained pMQ87Ap suicide vector. A 600-bp
fragment (nucleotides 100 to 700) of lipA was amplified with primers CT0150
(5⬘-GGAAACAGCTATGACCATGATTACGAATTCGAGCTCGGTACCCA
CCCCATCGTGCTGGCCCACGGCATGC) and CT0151 (5⬘-GTGCCAAGCT
TGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGAAGTTGGTCAG
CGGCGAGGAACCGC). Both pMQ87Ap and the PCR fragment obtained
were cut with the restriction enzymes BamHI and SacI. E. coli JM109 cells were
transformed by heat shock with the ligation mix. The transformants obtained
were checked by PCR with primers CT0142 (5⬘-CCAAGTACCCGCAGGGCA
TCCC) and P729 (5⬘-CAGACCGCTTCTGCGTTCTG). The selected transformants were conjugated into P. aeruginosa 3A8 in order to obtain lipA::
pMQ87Ap.
Construction of plipA. Plasmid plipA was constructed with the yeast-based
cloning system (31). The lipA gene from PA14 was amplified by PCR with
primers CT0144 (5⬘-CCATACCCGTTTTTTTGGGCTAGCGAATTCGAGCT
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CGGTACCCATGAAGAAGAAGTCTCTGCTCCCCC) and CT0145 (5⬘-GCC
AAGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCCCTACAGGC
TGGCGTTCTTCAGGCG). The 1,020-bp PCR fragment was cloned in the
vector pMQ70 (ampicillin resistant; linearized by digestion with SmaI) by in vivo
homologous recombination in yeast cells (31). Plasmids were recovered from the
yeast as described previously (31) and transformed into E. coli JM109, and
plasmid candidates were screened by PCR with primers CT0140 and CT0141
(see above) and sequenced with primers CT0140 and CT0143 (5⬘-CGTGCTGG
CGGTAGACGCTGAC). Selected transformants were conjugated into P.
aeruginosa PA14 for subsequent analysis.
Detection of oleic acid by HPLC. Bacterial cultures were grown overnight in
LB medium supplemented with vehicle or PS80 (0.01 or 0.1%). In the case of the
Pseudomonas species lipase sample, both the lipase (which was used at 0.1
mg/ml) and PS80 (which was used at 0.01%) were incubated in LB medium
overnight. After filtration, 40 ml of the supernatants was acidified with 400 l of
10% trifluoroacetic acid (TFA). SepPac cartridges (Waters Corporation, Milford, MA) were attached to 60-ml syringes and washed with 5 ml acetonitrile and
then 10 ml of 0.1% TFA. The acidified supernatants were applied to the cartridges at a rate of about 2 ml per minute. The cartridges were washed with 5 ml
of 0.1% TFA and then with 5 ml of a buffer containing 50% of 0.1% TFA and
50% acetonitrile. The cartridges were washed a third time with a buffer containing 5% of 0.1% TFA and 95% acetonitrile, and this fraction was dried under
vacuum in a Speedvac apparatus. The samples were resuspended in 65% buffer
B (0.13% TFA in acetonitrile)–35% buffer A (0.15% TFA in water) and analyzed
by high-pressure liquid chromatography (HPLC) with a chromatograph
equipped with a model G1316A diode array detector (Agilent Technologies Inc.,
Santa Clara, CA). The chromatographic separation was performed on a Waters
symmetry C18 column (5 m by 3.9 mm by 150 mm; Waters Corporation). A
binary buffer system consisting of buffer A and buffer B was used. The column
was equilibrated in 65% buffer B, and the gradient was developed over 30 min to
95% buffer B at a flow rate of 1.5 ml/min. The column was maintained at 35°C,
and the column effluent was monitored at a wavelength of 210 nm with a
bandwidth of 8 nm.

RESULTS
PS80 inhibits biofilm formation of P. aeruginosa PA14 without inhibiting planktonic growth. PS80 decreased the biofilm
formation of P. aeruginosa PA14, as measured by crystal violet
staining of microtiter wells (22), when it was used at a concentration of as low as 0.001% (Fig. 1A). The 0.01% concentration
of PS80 was chosen for use in the remaining experiments for
which results are presented, unless specified otherwise. We
confirmed this biofilm result by counting the numbers of CFU
of cells grown as biofilms on the wells of a 96-well PVC plate
(Fig. 1B). Wild-type (WT) PA14 cells treated with 0.01% PS80
showed a 100-fold reduction in attachment to the wells of the
PVC plate. The presence of PS80 did not alter the planktonic
growth of PA14 under the conditions used in our assays, as
measured by determination of the OD and the numbers of
CFU (data not shown). We also obtained a similar result for
biofilm formation when we tested a glass surface (data not
shown).
The effect of PS80 on cell attachment was not specific to
PVC but could be observed on several types of medically relevant abiotic surfaces (Fig. 1C). When P. aeruginosa PA14 cells
were incubated with the vehicle, an average of 59 ⫾ 10 cells per
microscopy field was attached to the PVC tabs, an average of
50 ⫾ 5 cells was attached to the etafilcon A contact lens, and
an average of 42 ⫾ 7 cells was attached to the vifilcon A lens.
However, in the presence of PS80, the levels of attachment
decreased more than 10-fold: 1 ⫾ 1 cell was attached to the
PVC tabs, 6 ⫾ 2 cells were attached to the etafilcon A lens, and
3 ⫾ 1 cells were attached to the vifilcon A lens.
Identification of a mutant resistant to the effect of PS80. To
begin to elucidate the mechanism by which PS80 mediates

FIG. 1. PS80 inhibits biofilm formation of P. aeruginosa PA14.
(A) Quantification of biofilms formed in PVC microtiter plates after a
24-h incubation at 37°C. The histograms represent the average of four
replicates per condition tested, and the error bars denote the standard
deviation. (B) CFU of biofilm cells attached to PVC wells of microtiter
plates after a 24-h incubation at 37°C. (C) Top-down phase-contrast
micrographs of biofilms formed on PVC tabs or two different contact
lens polymers after a 24-h incubation at 37°C. Bars, 20 m. Cells were
grown in LB medium (A and B) or M63-glucose-Casamino Acids
(C) supplemented with vehicle or PS80 (0.01%).
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FIG. 2. Mutant 3A8 is resistant to the effect of PS80 and overexpresses the lipA-encoded lipase. (A) Quantification of biofilms formed by strain
PA14 and mutant 3A8 in PVC microtiter plates after a 24-h incubation at 37°C. The graph presents the average and standard deviation of four
replicates. (B) qRT-PCR measuring lipA gene expression (the results are averages of four independent experiments). Expression is plotted as the
the number of picograms of input cDNA for each strain. (C) Lipase activity assay with a tributyrin emulsion plate (see Materials and Methods).
C⫹, purified Pseudomonas species lipase (type XIII, 0.1 mg/ml); sup, supernatant; ⌬sup, heat-inactivated supernatant. The average diameter of the
zone of clearing is shown below each image. (D) The supernatants from overnight cultures of PA14 and 3A8 were filtered and added to the biofilm
assays at a 0.1% concentration. A purified lipase (type XIII) at concentrations of 0.1 or 0.01 mg/ml was also added to a biofilm assay of PA14 cells.
Gray bars, LB medium supplemented with vehicle; white bars, LB medium supplemented with PS80 (0.01%).

biofilm inhibition of strain PA14, we searched for mutants of
PA14 with the capacity to form biofilms in the presence of
0.01% PS80. Toward that goal, we screened the transposon
PA14 mutant library generated by Ausubel and colleagues
(16). One mutant, named 3A8, showed strong and reproducible resistance to the effect of PS80 (Fig. 2A). The biofilm
formation of 3A8 was comparable to that of the WT strain in
the absence of PS80, but unlike the WT, its ability to form
biofilms in the presence of PS80 was not affected.
The 3A8 mutant has a mariner transposon inserted at the 3⬘
end of ligT (PA14_27110), annotated as a 2⬘-5⬘ RNA ligase
gene (http://v2.pseudomonas.com). The ligT gene is directly
upstream of lipA (PA14_27100), which codes for an extracel-

lular lipase. The lipases in bacteria have been extensively studied and are known to be able to cleave and degrade detergents
such as PS80 (10).
We hypothesized that the known mariner transposon promoter might result in the increased expression of lipA. A qRTPCR experiment demonstrated that the level of transcription
of lipA was increased about 250-fold in mutant 3A8 (1.3129 ⫾
0.0034) compared to that in WT strain PA14 (0.0053 ⫾ 0.0003)
(Fig. 2B). This result suggested to us that the resistance to
PS80 seen in 3A8 might be related to the overexpression of
lipA.
The supernatant of 3A8 confers resistance to PS80. If the
PS80 resistance of mutant 3A8 were due to higher levels of
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FIG. 3. The deletion and multicopy expression of lipA show that the overexpression of LipA is associated with resistance to PS80 in mutant 3A8.
(A and C) Lipase activity assay on tributyrin elmulsion plates (see Materials and Methods). C⫹, purified Pseudomonas species lipase (0.1 mg/ml);
lipA::pMQ87Ap, single-crossover knockout mutant of lipA in the mutant 3A8 background; pMQ70, vector carried by WT strain PA14; plipA, lipA
gene cloned on pMQ70, carried by WT PA14. (B and D) Biofilm assay performed as described in the legend to Fig. 1. Gray bars, LB medium
supplemented with vehicle; white bars, LB medium supplemented with PS80 (0.01%). Where indicated, strains carrying pMQ70 and plipA were
grown with 0.2% arabinose (⫹Ara).

expression and secretion of LipA, we would predict that filtered supernatants of 3A8 would contain a concentration of
secreted LipA higher than that in the WT and would demonstrate a higher level of lipase activity. These cell-free supernatants were tested on a tributyrin emulsion plate, which is used
to detect lipase activity through the clearing of the lipid emulsion. The WT PA14 supernatant had no detectable lipase activity even after 3 days of incubation (0 ⫾ 0 mm of tributyrin
clearing), whereas we could visualize strong lipase activity with
the 3A8 supernatant (13.3 ⫾ 0.8 mm of tributyrin clearing) by
day 3 (Fig. 2C).
We tested the ability of WT strain PA14 to form biofilms in
the presence of PS80 and a 1:10 dilution of filtered supernatant
prepared from an overnight culture of either the WT strain or
mutant 3A8. The WT cells incubated with the WT supernatant
could not form biofilms in the presence of PS80, but the same
cells incubated with the supernatant derived from the 3A8
mutant showed attachment to PVC in the presence of PS80 at
the same level as in the presence of the vehicle alone (Fig. 2D).
To further show that the resistance of mutant 3A8 was due
to the production of the LipA enzyme, we tested filtered supernatants after treatment at 65°C for 20 min to denature the
proteins present in the sample. As expected, WT cells supplemented with heated 3A8 supernatant did not form a biofilm in

the presence of PS80 (Fig. 2D). When the same supernatant
was tested on a tributyrin plate, no lipase activity could be
detected (Fig. 2C). Taken together these results suggest that
the 3A8 mutant secretes a heat-labile lipase that is associated
with resistance to PS80.
We also tested the effect of a purified, commercially available lipase (type XIII) purified from Pseudomonas species on
the biofilm formation of WT PA14 cells. When the bacteria
were grown in the presence of both PS80 and the purified
lipase (at a concentration of either 0.1 or 0.01 mg/ml), they
formed biofilms as well as they did when they were treated with
the vehicle alone (Fig. 2D).
The overexpression of LipA is associated with the resistance
to PS80 and biofilm formation. To provide additional evidence
that the resistance phenotype observed in mutant 3A8 was due
to the overproduction of LipA, we constructed a single-crossover knockout mutant of lipA (the lipA::pMQ87Ap mutant) in
the 3A8 background. This mutant showed a drastic reduction
in the level of lipA transcription by qRT-PCR (data not
shown). On tributyrin emulsion plates, the filtered supernatant
of a culture of lipA::pMQ87Ap showed no lipase activity, similar to the result for strain PA14 and in contrast to the result
for its parental strain, 3A8 (Fig. 3A). In a biofilm assay, lipA::
pMQ87Ap and 3A8 had similar levels of biofilm formation in
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the absence of PS80, but when they were incubated with PS80,
lipA::pMQ87Ap lost its ability to form biofilm compared to
that of mutant 3A8 and showed a phenotype similar to that of
PA14 (Fig. 3B).
We also cloned lipA under the control of the PBAD inducible
promoter and introduced this construct in WT strain PA14. On
tributyrin emulsion plates, the filtered supernatant of a WT
culture containing the plipA construct showed some lipase
activity without the addition of arabinose, whereas the control
showed no lipase activity. However, when cells containing
plipA were grown in the presence of 0.2% arabinose, the lipase
activity observed on these emulsion plates reached a level
similar to what was measured for 3A8 (Fig. 3C). When WT
cells transformed with plipA were tested in a biofilm assay in
the presence of PS80, they formed as much biofilm as they did
when they were incubated without PS80, upon induction with
0.2% arabinose (Fig. 3D). Taken together, these results suggest that the overexpression of lipA in mutant 3A8 is directly
associated with the resistance to PS80 and biofilm formation.
PS80 is degraded to oleic acid by the filtered supernatant of
mutant 3A8. Some lipases are known to have an esterase activity that allows them to cleave detergents at their ester bond
(10). We postulated that lipases, including LipA, are able to
render PS80 inactive by cleaving it at its ester bond (Fig. 4A).
This cleavage should lead to the production of an alcohol and
oleic acid. Consistent with this premise, we noted a reduction
in the pH of the 3A8 supernatant on modified lipase activity
plates prepared with 0.01% PS80, in place of tributyrin, and
amended with phenol red, a pH indicator (data not shown).
We next analyzed filtered supernatants of mutant 3A8 for
their ability to degrade PS80. While we could not directly
monitor the supernatants for PS80, we could assess the accumulation of oleic acid, one product of PS80 generated when
this compound is cleaved at its ester bond. We incubated the
supernatants of 3A8 with the vehicle or PS80 and analyzed the
resulting supernatant by HPLC on a C18 HPLC column to
detect the formation of oleic acid. Analysis of the supernatant
of 3A8 incubated with PS80 (0.01%) led to the detection of a
small peak at the retention time for oleic acid (⬃18.6 min)
(Fig. 4B).
In a control experiment, no peak at the retention time for
oleic acid could be detected in the supernatant of mutant 3A8
when it was incubated with vehicle alone (Fig. 4C). When 3A8
was incubated with 10-fold more PS80 (0.1%), we could detect
a larger peak at the retention time corresponding to that for
oleic acid (Fig. 4D). This result indicates that the production of
oleic acid depends, at least in part, on the initial concentration
of PS80 present in the solution.
To confirm our conclusion that the peak at 18.6 min corresponds to oleic acid, we spiked the mutant 3A8 supernatant
containing 0.01% PS80 with commercially available purified
oleic acid at a concentration of 0.01%. The peak detected in
this spiked sample had a similar retention time of 18.6 min,
suggesting that we had detected the production of oleic acid in
our samples (Fig. 4E). No peak at the retention time of 18.6
min could be detected for samples purified from the WT strain
incubated with vehicle alone (control experiment; Fig. 4F) or
with PS80 (0.01%) (Fig. 4G), indicating that PS80 is not
cleaved under the conditions tested. It should also be noted
that, unlike PS80, commercially available oleic acid at a con-
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centration of 0.01% did not lead to a reduction in the level of
biofilm formation by WT strain PA14 (data not shown).
We also tested if the commercially available Pseudomonas
species lipase (type XIII) was able to cleave PS80. When the
mix of the lipase and PS80 was incubated overnight at 37°C, a
peak at the retention time for oleic acid could be detected
(data not shown). If a similar mix was tested by HPLC without
incubation, no peak corresponding to oleic acid could be detected. Taken together, these data suggest that the cleavage of
PS80 to oleic acid occurs in the presence of lipases and that a
lipase capable of such activity is present in the supernatant of
mutant 3A8.
A surfactant with an ether bond inhibits the biofilm formation of mutant 3A8. Given our evidence suggesting that PS80 is
cleaved by LipA in the filtered supernatant of mutant 3A8, we
postulated that a surfactant containing a lipase-resistant ether
bond would inhibit the biofilm formation of the LipA-overproducing mutant. To address this question, we tested the surfactant polyethoxylated(20) oleyl alcohol, which has a chemical
structure similar to that of PS80 (Fig. 4A). Importantly, polyethoxylated(20) oleyl alcohol contains an ether bond, which
lipases cannot cleave, in place of the ester bond present in
PS80.
Biofilm assays showed that both WT strain PA14 and mutant
3A8 were equally inhibited by polyethoxylated(20) oleyl alcohol (Fig. 5), and the presence of this compound in the medium
did not lead to any alteration of the growth of the strains tested
(data not shown).
PS80 inhibits biofilm formation of other clinical isolates of
P. aeruginosa and other gram-negative and -positive bacteria.
We were interested in whether the effect of PS80 on biofilm
formation could be observed in P. aeruginosa clinical isolates as
well as other bacterial species. We tested a collection of gramnegative and gram-positive clinical isolates and identified 255
strains that were able to form a biofilm when they were grown
in LB medium supplemented with the vehicle. Seventy-five of
the 255 isolates had reduced planktonic growth when they were
incubated with PS80 and were not further tested. The remaining 180 isolates were tested for biofilm formation in the presence of 0.01% PS80 and were categorized as biofilm formation
inhibited when at least a 50% decrease in the level of biofilm
formation was observed in the presence of PS80 (Table 1).
Of the 180 remaining isolates, 101 were P. aeruginosa, and
biofilm formation was inhibited by PS80 in 45% of these of 101
isolates. All P. aeruginosa clinical strains were also tested for
lipase production on tributyrin emulsion plates. Of the isolates
able to form biofilms in the presence of PS80, 25% showed
increased lipase activity on the plates compared to that of WT
strain PA14 (Table 1). Biofilm formation in the presence of
polyethoxylated(20) oleyl alcohol was also tested; 80% of the
isolates able to form biofilms in the presence of PS80 also
formed biofilms in the presence of polyethoxylated(20) oleyl
alcohol, but only 25% of these isolates had increased lipase
activity (data not shown). The existence of PS80- and polyethoxylated(20) oleyl alcohol-resistant strains suggests that
there are mechanisms for resisting the antibiofilm effects of
surfactants that do not involve lipase-mediated degradation of
the surfactant.
Incubation with PS80 inhibited the biofilm formation of all of
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FIG. 4. Oleic acid is a product of LipA-mediated PS80 degradation. (A) Chemical structures of PS80 and polyethoxylated(20) oleyl alcohol
(courtesy of Alex Pletnev, Department of Chemistry, Dartmouth College). The arrow shows the ester bond of PS80 expected to be cleaved by
lipases. (B to G) HPLC traces of various supernatants. The arrows indicate the retention time for oleic acid. (B and D) Analysis of the supernatants
of mutant 3A8 to which PS80 at 0.01% (B) and 0.1% (D) was added. The oleic acid peak is detected at the retention time of ⬃18.6 min and is
dose dependent (compare the peaks in panels B and D). (C) Mutant 3A8 supernatant with no added PS80 used as a control. (E) Control in which
the 3A8 supernatant was spiked with 0.01% oleic acid. (F) The WT PA14 supernatant with no added PS80 used as a control. (G) The WT
supernatant with added PS80 (0.01%). mAU, milli-absorbance units.

the Escherichia coli and Klebsiella sp. isolates tested (Table 1).
Biofilm formation was inhibited in most gram-positive bacterial
species tested in the presence of PS80, including Staphylococcus
epidermidis (100% of the tested isolates), Staphylococcus saprophyticus (100%), coagulase-negative Staphylococcus (97.5%),
Enterococcus sp. (100%), and Streptococcus mutans (100%)
(Table 1). In contrast, biofilm formation was inhibited in only

66.7% of Staphylococcus aureus isolates in the presence of
PS80 (Table 1). Moreover, all S. aureus isolates able to form
biofilms in the presence of PS80 showed high levels of lipase
activity when it was measured on tributyrin emulsion plates,
whereas none of the coagulase-negative staphylococci showed
any lipase activity, reinforcing the idea that non-lipase-dependent mechanisms of resistance to PS80 exist (Table 1).
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FIG. 5. Polyethoxylated(20) oleyl alcohol inhibits biofilm formation by WT strain PA14 and mutant 3A8. Biofilm assays were performed as described in Materials and Methods. LB medium was supplemented with either vehicle (dark gray bars), PS80 (0.01%; white
bars), or polyethoxylated(20) oleyl alcohol (0.01%; light gray bars).

P. aeruginosa PAO1 is resistant to PS80 but does not overproduce LipA. In addition to all the clinical isolates, we also
tested the other commonly used P. aeruginosa laboratory
strains, PAK and PAO1. Strain PAK was found to be inhibited
in the presence of PS80 at concentrations similar to those that
inhibited strain PA14 (data not shown), whereas P. aeruginosa
PAO1 could still form a biofilm in the presence of 0.01% PS80
(Fig. 6A), as well as in the presence of polyethoxylated(20)
oleyl alcohol. Strain PAO1 was able to form biofilms in the
presence of PS80 at concentrations as high as 2% (data not
shown). Unlike mutant 3A8, the filtered supernatant of strain
PAO1 could not restore biofilm formation when it was added
to a biofilm assay with PA14 cells in the presence of PS80 (Fig.
6A). Moreover, PAO1 did not show any lipase expression

TABLE 1. Effect of PS80 (0.01%) on ability to form biofilms by
clinical isolates of gram-negative and gram-positive
bacterial species
% of clinical isolates with:
Species

Pseudomonas aeruginosa
Escherichia coli
Klebsiella spp.
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus saprophyticus
Coagulase-negative
Staphylococcus
Enterococcus sp.
Streptococcus mutans
a

No. of
clinical
isolates

Inhibition of
biofilm
formation in
presence of
PS80a

Lipase activityb
and ability to
form biofilms
in presence of
PS80

101
6
7
12
11
1
40

45
100
100
66.7
100
100
97.5

25
NAc
NA
100
NA
NA
0

100
100

NA
NA

1
1

None of the strains had an obvious growth defect in the presence of PS80
(data not shown).
b
The lipase activity was measured on tributyrin emulsion plates (see Materials
and Methods).
c
NA, not applicable. None of the clinical isolates were able to form biofilms
in the presence of PS80.

FIG. 6. Strain PAO1 is resistant to the effect of PS80, but the
overexpression of a lipase is not involved. (A) Biofilm assays were
performed as described in Materials and Methods. LB medium was
supplemented with either vehicle (dark gray bars), PS80 (0.01%; white
bars), or polyethoxylated(20) oleyl alcohol (0.01%; light gray bars).
The supernatants from overnight cultures of strains PA14 and PAO1
were filtered and added to the biofilm assays with PA14 cells at a 0.1%
concentration. (B) Lipase activity assay on tributyrin emulsion plates
(see Materials and Methods). C⫹, purified Pseudomonas species lipase
(0.1 mg/ml). (C) qRT-PCR measuring lipA expression (the results are
the averages of two independent experiments). Expression is plotted as
the number of picograms of input cDNA for each strain. Data for the
level of lipA expression in mutant 3A8 were added on the right of the
graph to show the differences in scales between PA14, PAO1, and 3A8.

when it was measured on tributyrin emulsion plates (Fig. 6B),
suggesting that the mechanism of resistance of this strain is
different from that of mutant 3A8 and does not involve the
overproduction of LipA. To verify this hypothesis further, we
measured the level of expression of lipA by qRT-PCR and
showed that PAO1 has a low level of transcription of lipA,
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FIG. 7. Higher concentrations of PS80 lead to disrupted strain
PA14 biofilms. The biofilm assay was performed as described in Materials and Methods. After a 24-h incubation, the LB medium was
replaced with LB medium supplemented with either the vehicle or
PS80 at a concentration of 2, 1, 0.5, or 0.01%. The biofilm assays were
then incubated for another 24 h before they were quantified.

similar to that of PA14 and unlike that of 3A8, as shown in Fig.
6C. Taken together, these data suggest that PAO1 has a nonlipase-dependent pathway of PS80 resistance.
The addition of higher concentrations of PS80 can disrupt
already formed biofilms. All the data presented so far show
that PS80 does not allow WT strain PA14 cells to bind to the
surface in order to develop a biofilm, but what about preexisting biofilms?
We tested the effect of PS80 on preformed biofilms and
showed that the concentration of 0.01% used throughout this
work was not able to disrupt an established biofilm formed by
PA14 on PVC (Fig. 7). Nevertheless, when the concentration
of PS80 was increased to 0.5, 1%, or 2%, no biofilm remained
on the PVC wells (Fig. 7). This shows that bacterial biofilms
could be disrupted in the presence of higher concentrations of
PS80.
DISCUSSION
PS80 is a surfactant and emulsifier used by the cosmetic,
food, and pharmaceutical industries at concentrations that
range from 0.1% to over 1% (Center for Food Safety and
Applied Nutrition, U.S. Food and Drug Administration, http:
//www.cfsan.fda.gov/⬃dms/opa-appa.html). We have demonstrated that concentrations of PS80 at least 10 times lower than
those commonly used can inhibit biofilm formation by P.
aeruginosa PA14 as well as numerous other P. aeruginosa clinical isolates, including gram-negative and -positive isolates.
The suppression of P. aeruginosa biofilm formation by PS80
was observed when it was tested with a variety of abiotic surfaces of medical relevance, including contact lenses. Additionally, at higher concentrations, such as 1%, PS80 was able to
disrupt preformed biofilms of PA14. The detection of these
effects at concentrations of PS80 known to be well tolerated by
human tissues (21) suggests that PS80 or a related compound
might have therapeutic value.
However, we found that many strains of P. aeruginosa are
resistant to the effect of PS80. The identification of a transposon mutant (mutant 3A8) and studies with that mutant helped
address the resistance of at least a subset of isolates. This
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mutated strain overexpresses the lipase LipA, which, when it is
secreted, results in the cleavage of PS80 into an alcohol and
oleic acid. Cell-free supernatants containing high levels of
LipA alone or commercially available purified lipase conferred
resistance to PS80 to WT cells. A similar effect was also observed when lipA was overexpressed on a plasmid in the WT
cells. Taken together, these data lead to the conclusion that the
PS80 resistance observed in mutant 3A8 is due to the presence
of a higher concentration of LipA in the culture supernatant.
Polyethoxylated(20) oleyl alcohol is structurally similar to PS80
but has an ether bond in place of the ester bond in PS80.
Importantly, this surfactant was able to inhibit the biofilm
formation of strain PA14 as well as that of mutant 3A8. We
hypothesize that polyethoxylated(20) oleyl alcohol’s activity
against the 3A8 mutant is due to the presence of its lipaseresistant ether bond that links its hydrophilic and hydrophobic
moieties, which renders it resistant to cleavage by the lipase
LipA.
While some of the PS80-resistant clinical P. aeruginosa
strains did show evidence of lipase secretion, approximately
75% did not. Moreover, 80% of all these PS80-resistant strains
formed biofilms in the presence of polyethoxylated(20) oleyl
alcohol, suggesting that additional mechanisms for resisting
the antibiofilm effect of PS80 and related compounds exist. We
reached a similar conclusion for the PAO1 strain of P. aeruginosa, which was resistant to the effect of PS80, even at high
concentrations (up to 2%), as well as polyethoxylated(20) oleyl
alcohol, but which did not show any involvement of a lipase in
its resistance mechanism. More work is necessary to understand these non-lipase-dependent pathways to surfactant resistance.
Previous studies have addressed the ability of surfactants to
alter biofilm formation and have obtained different results.
Consistent with the idea that it can prevent bacterial attachment, PS80 (used at 0.01%) has been shown to play a role in
the disruption of a microbe-peat association (1). While Mireles
et al. (20) reported that surfactin as well as sodium dodecyl
sulfate and PS80 (used at 0.25%) were effective at inhibiting
biofilm formation by Escherichia coli, Salmonella enterica, and
Proteus mirabilis on catheters, they did not observe any inhibition of biofilm formation by P. aeruginosa. As noted, we found
that PS80’s inhibitory effect applies to many but not all strains
of P. aeruginosa tested, including the laboratory strain P.
aeruginosa PAO1. The authors of that study did not specify the
strain of P. aeruginosa used, so it is possible that they were
testing P. aeruginosa PAO1, which we found to be resistant to
PS80’s inhibitory effect on biofilm formation. They go on to
make the suggestion that there is an inverse relationship between the presence of surfactants and biofilm formation. Our
data do not contradict this suggestion but suggest that some
strains are resistant to these surfactant-mediated effects.
Potential clinical applications of the antibiofilm effect of
PS80 or derivatives include the treatment of medical prosthetic
devices, such as artificial joints and intraocular lenses, prior to
implantation. For these types of implants, contamination typically occurs during implantation, but if the bacteria are
cleared, reinoculation of the implant is unlikely. This application may be the most relevant, since our data indicate that
PS80 prevents bacterial biofilm formation even when it is used
at very low concentrations. In contrast, there are medical de-
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vices such as catheters and contact lenses which experience
bacterial reinoculation while in use. To be effective for these
types of devices experiencing recontamination, it would be
important to create a schedule of repeated applications of
PS80 by the use of higher concentrations to disrupt biofilms
that may form over time. Another strategy which might prevent bacterial attachment would be to permanently bind PS80
or a derivative to the surface of the device. Finally, clinical
applications will require PS80 to work effectively in a polymicrobial environment. While our data showing that PS80 inhibits bacterial biofilm formation by a broad range of microbes are
encouraging, additional work will be necessary to optimize
these properties in a clinical setting.
Further work is also necessary to identify the mechanism by
which PS80 inhibits biofilm formation. PS80 and related surfactants may act primarily by modifying the abiotic surface in
such a way that it becomes resistant to bacterial attachment or
by altering bacterial physiology to render the strains less fit to
form biofilms. A better understanding of the mechanisms by
which surfactants inhibit biofilm formation will help in the
design of compounds of therapeutic value.
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